Open AccessClinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
Author(s) -
Trimarchi Matteo,
Indelicato Pietro,
Vinciguerra Alessandro,
Bussi Mario
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3792
Subject(s) - dupilumab , medicine , chronic rhinosinusitis , nasal polyps , clinical trial , sinusitis , dermatology , clinical efficacy , disease , randomized controlled trial , surgery , intensive care medicine , atopic dermatitis
Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom